tiprankstipranks
Protalix Biotherapeutics (DE:PBDA)
FRANKFURT:PBDA

Protalix (PBDA) Ownership - Who Owns Protalix?

0 Followers

Protalix (PBDA) Ownership Overview

0.00%0.00%1.67%98.33%
1.67% Other Institutional Investors
98.33% Public Companies and
Individual Investors
The ownership structure of Protalix (DE:PBDA) stock is a mix of institutional, retail and individual investors. Approximately 1.67% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 98.33% is owned by Public Companies and Individual Investors.
The ownership structure of Protalix (DE:PBDA) stock is a mix of institutional, retail and individual investors. Approximately 1.67% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 98.33% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Oct 20, 2023
Dror Bashan
President & Ceo,director
Bought$90484

Recent Hedge Fund Trading Activity

Currently, No Data Available
Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
102,000Insider102,918
195,000Insider196,755
673,754Insider679,818
185,000Insider186,665
24,112,510Insider24,329,523
2Institution2
299,534Institution320,801
12,042Institution12,897
2,235,480Institution2,394,199
1,878Institution2,012

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
5,761Institution6,170
12,658Institution13,557
2,660Institution2,849
25,561Institution27,376
120,000Institution128,520
258,165Institution276,495
29,265Institution31,343
724,482Institution775,920
205,000Institution219,555
30,000Institution32,130

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Protalix Biotherapeutics (DE:PBDA)?
According to the latest TipRanks data, approximately 1.67% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 98.33% is held by retail investors.
    What percentage of Protalix Biotherapeutics (DE:PBDA) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 1.67% of Protalix Biotherapeutics (DE:PBDA) stock is held by institutional investors.
      What percentage of Protalix Biotherapeutics (DE:PBDA) stock is held by retail investors?
      According to the latest TipRanks data, approximately 98.33% of Protalix Biotherapeutics (DE:PBDA) stock is held by retail investors.
        Who owns the most shares of Protalix Biotherapeutics (DE:PBDA)?
        Tzvi Palash owns the most shares of Protalix Biotherapeutics (DE:PBDA).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis